CNS Pharmaceuticals, Inc.
CNSP
$5.52
-$0.60-9.80%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.45% | 41.46% | 713.21% | 1,500.54% | 1,077.58% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -33.83% | 282.45% | 212.95% | -16.83% | 54.12% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 120.87% | 62.45% | -15.48% | -- | -89.85% |
| Total Current Assets | -6.42% | 54.19% | 558.98% | 756.93% | 444.15% |
|
|
|||||
| Total Current Assets | -6.42% | 54.19% | 558.98% | 756.93% | 444.15% |
| Net Property, Plant & Equipment | 195.00% | 10.71% | 5.56% | 13.95% | 22.45% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1,281.87% | 2,478.26% | 14.36% | -59.49% | -65.27% |
| Total Assets | -0.89% | 60.19% | 487.53% | 727.82% | 411.55% |
|
|
|||||
| Total Accounts Payable | 71.60% | -52.10% | -81.01% | -56.31% | -62.31% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 0.77% | -1.28% | -1.14% | -1.13% | 8.41% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 62.46% | -51.71% | -79.55% | -54.38% | -58.84% |
|
|
|||||
| Total Current Liabilities | 62.46% | -51.71% | -79.55% | -54.38% | -58.84% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 0.77% | -1.28% | -1.14% | -1.13% | 8.41% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 62.46% | -51.71% | -79.55% | -54.38% | -58.84% |
|
|
|||||
| Common Stock & APIC | 15.67% | 23.20% | 46.08% | 45.16% | 39.10% |
| Retained Earnings | -18.77% | -16.09% | -20.44% | -21.36% | -21.36% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -26.78% | 195.62% | 405.69% | 347.60% | 239.36% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -26.78% | 195.62% | 405.69% | 347.60% | 239.36% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -26.78% | 195.62% | 405.69% | 347.60% | 239.36% |
|
|
|||||